关注
Bernard A. Fox
Bernard A. Fox
Harder Family Chair for Cancer Research, Member and Chief, Molecular & Tumor Immunology, Earle A
在 providence.org 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ...
The Lancet 391 (10135), 2128-2139, 2018
18652018
Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours
J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ...
The Journal of pathology 232 (2), 199-209, 2014
15062014
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
GJ Nabel, EG Nabel, ZY Yang, BA Fox, GE Plautz, X Gao, L Huang, S Shu, ...
Proceedings of the National Academy of Sciences 90 (23), 11307-11311, 1993
12591993
Cancer classification using the Immunoscore: a worldwide task force
J Galon, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, A Berger, ...
Journal of translational medicine 10 (1), 1-10, 2012
9582012
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
T Duhen, R Duhen, R Montler, J Moses, T Moudgil, NF de Miranda, ...
Nature communications 9 (1), 1-13, 2018
7472018
The immune score as a new possible approach for the classification of cancer
J Galon, FM Marincola, M Thurin, G Trinchieri, BA Fox, TF Gajewski, ...
Journal of translational medicine 10 (1), 1-4, 2012
6082012
OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer PatientsTargeting OX40 in Cancer Patients
BD Curti, M Kovacsovics-Bankowski, N Morris, E Walker, L Chisholm, ...
Cancer research 73 (24), 7189-7198, 2013
5622013
Cancer and inflammation: promise for biologic therapy
S Demaria, E Pikarsky, M Karin, LM Coussens, YC Chen, EM El-Omar, ...
Journal of immunotherapy 33 (4), 335-351, 2010
4122010
Granulocyte–macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non–small-cell lung cancer
J Nemunaitis, D Sterman, D Jablons, JW Smith, B Fox, P Maples, ...
Journal of the National Cancer Institute 96 (4), 326-331, 2004
3262004
Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy
KH Young, JR Baird, T Savage, B Cottam, D Friedman, S Bambina, ...
PloS one 11 (6), e0157164, 2016
3082016
Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40Timing Is Critical for OX40 plus PD-1 Combination
DJ Messenheimer, SM Jensen, ME Afentoulis, KW Wegmann, Z Feng, ...
Clinical Cancer Research 23 (20), 6165-6177, 2017
3042017
Neoantigen T-cell receptor gene therapy in pancreatic cancer
R Leidner, N Sanjuan Silva, H Huang, D Sprott, C Zheng, YP Shih, ...
New England Journal of Medicine 386 (22), 2112-2119, 2022
2852022
Novel technologies and emerging biomarkers for personalized cancer immunotherapy
J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ...
Journal for immunotherapy of cancer 4 (1), 1-25, 2016
2682016
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer
J Nemunaitis, T Jahan, H Ross, D Sterman, D Richards, B Fox, D Jablons, ...
Cancer gene therapy 13 (6), 555-562, 2006
2582006
Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.
AE Chang, A Aruga, MJ Cameron, VK Sondak, DP Normolle, BA Fox, ...
Journal of clinical oncology 15 (2), 796-807, 1997
2251997
Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile
HM Hu, WJ Urba, BA Fox
The Journal of Immunology 161 (6), 3033-3041, 1998
1991998
Defining the critical hurdles in cancer immunotherapy
BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ...
Journal of translational medicine 9 (1), 1-15, 2011
1902011
Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors
GJ Nabel, A Chang, EG Nabel, G Plautz, BA Fox, L Huang, S Shu
Human gene therapy 3 (4), 399-410, 1992
1841992
Signaling through OX40 enhances antitumor immunity
SM Jensen, LD Maston, MJ Gough, CE Ruby, WL Redmond, M Crittenden, ...
Seminars in oncology 37 (5), 524-532, 2010
1732010
Development of antitumor immune responses in reconstituted lymphopenic hosts
HM Hu, CH Poehlein, WJ Urba, BA Fox
Cancer research 62 (14), 3914-3919, 2002
1702002
系统目前无法执行此操作,请稍后再试。
文章 1–20